8 completed, 1 unknown. 9 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 9 | Completed 8, Unknown 1 |
| Phase 2 | 2 | Completed 2 |
Follow PegBio Co., Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PB-119 Injection in Chinese Obese Subjects PB-119, Placebo - Obesity | Phase 1 / Phase 2 | Completed | PegBio Co., Ltd. | 32 | 2024-05-27 | 2025-11-19 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PB-718 Injection in Chinese Obese Subjects. PB-718, Placebo - Obesity | Phase 1 / Phase 2 | Completed | PegBio Co., Ltd. | 36 | 2023-07-06 | 2024-04-19 |
| Study to Evaluate the Pharmacokinetic Characteristics of Pegylated Exenatide Injection (PB-119) in Subjects With Different Degrees of Renal Insufficiency and Matched Subjects With Normal Renal Function PB119 - Type2Diabetes | Phase 1 | Unknown | PegBio Co., Ltd. | 24 | 2022-05-01 | 2022-04-14 |
| A Phase 1, Double-blind, Randomized, Placebo-controlled, Single- and Multiple-dose Escalating Study Placebo, PB 718 - Healthy Subjects | Phase 1 | Completed | PegBio Co., Ltd. | 82 | 2020-07-29 | 2022-09-28 |
| Clinical Trial for the Investigational Drug (PB-201) in Subjects With Type 2 Diabetes Mellitus glucokinase activator, Placebo - Type2 Diabetes Mellitus | Phase 1 | Completed | PegBio Co., Ltd. | 16 | 2019-08-27 | 2020-01-22 |
| MAD Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PB-119 to Subjects With T2DM PB-119 injection, PB-119 injection placebo - Type2 Diabetes Mellitus | Phase 1 | Completed | PegBio Co., Ltd. | 40 | 2015-11-24 | 2018-04-20 |
| Clinical Trial for PB-119 in Subjects With Type 2 Diabetes Mellitus Exenatide injection(Byetta), PB-119 injection - Type II Diabetes Mellitus | Phase 1 | Completed | PegBio Co., Ltd. | 36 | 2015-04-08 | 2017-02-23 |
| Continuous Multiple Dose PB-119 Injection in Health Volunteers PB-119 injection - Type2 Diabetes Mellitus | Phase 1 | Completed | PegBio Co., Ltd. | 36 | 2014-11-15 | 2017-02-23 |
| Clinical Trial for PB-119 in Healthy Subjects (Phase I) PB-119 - Type II Diabetes | Phase 1 | Completed | PegBio Co., Ltd. | 70 | 2014-02-01 | 2017-02-14 |
Diabetes Mellitus, Type 2 (2) · Obesity (2) · Hypoglycemia (1)
Lead-201 (1) · glucokinase activator compound 50 (1)
China (7) · United States (2)
Gregory Tracey, Dr. (1) · Guoping Yang, Ph D (1) · HaiYan Li (1) · Hugh Coleman, MD (1) · Jia Miao, MD,PhD (1) · Ping Fu, MD,PhD (1) · Ping Jin, Ph D (1) · Yuan LV (1) · Yuan Lv (1) · Yuan Lv, Doctor (1)